Literature DB >> 24122490

The importance of molecular complexity in the design of screening libraries.

Shahul H Nilar, Ngai Ling Ma, Thomas H Keller.   

Abstract

The one-dimensional model of Hann et al. (JChem Inf Comput Sci 41(3):856–864) has been extended to include reverse binding and wrap-around interaction modes between the protein and ligand to explore the complete combinatorial matrix of molecular recognition. The cumulative distribution function of the Maxwell–Boltzmann distribution has been used to calculate the probability of measuring the sensitivity of the interactions as the asymptotic limits of the distribution better describe the behavior of the interactions under experimental conditions. Based on our model, we hypothesized that molecules of lower complexity are preferred for target based screening campaigns, while augmenting such a library with moieties of moderate complexities maybe better suited for phenotypic screens. The validity of the hypothesis has been assessed via the analysis of the hit rate profiles for four ChemBL datasets for enzymatic and phenotypic screens.

Mesh:

Substances:

Year:  2013        PMID: 24122490     DOI: 10.1007/s10822-013-9683-1

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  40 in total

Review 1.  Small-molecule inhibitors of protein-protein interactions: progressing towards the dream.

Authors:  Michelle R Arkin; James A Wells
Journal:  Nat Rev Drug Discov       Date:  2004-04       Impact factor: 84.694

Review 2.  Three-dimensional pharmacophore methods in drug discovery.

Authors:  Andrew R Leach; Valerie J Gillet; Richard A Lewis; Robin Taylor
Journal:  J Med Chem       Date:  2010-01-28       Impact factor: 7.446

3.  Fragment-based lead discovery grows up.

Authors:  Monya Baker
Journal:  Nat Rev Drug Discov       Date:  2013-01       Impact factor: 84.694

4.  Matched molecular pair analysis of small molecule microarray data identifies promiscuity cliffs and reveals molecular origins of extreme compound promiscuity.

Authors:  Dilyana Dimova; Ye Hu; Jürgen Bajorath
Journal:  J Med Chem       Date:  2012-10-22       Impact factor: 7.446

Review 5.  Application of high-throughput, molecular-targeted screening to anticancer drug discovery.

Authors:  Robert H Shoemaker; Dominic A Scudiero; Giovanni Melillo; Michael J Currens; Anne P Monks; Alfred A Rabow; David G Covell; Edward A Sausville
Journal:  Curr Top Med Chem       Date:  2002-03       Impact factor: 3.295

6.  Development and NMR validation of minimal pharmacophore hypotheses for the generation of fragment libraries enriched in heparanase inhibitors.

Authors:  Rafael Gozalbes; Silvia Mosulén; Rodrigo J Carbajo; Antonio Pineda-Lucena
Journal:  J Comput Aided Mol Des       Date:  2009-05-07       Impact factor: 3.686

7.  Strategies and challenges involved in the discovery of new chemical entities during early-stage tuberculosis drug discovery.

Authors:  Geoffrey D Coxon; Christopher B Cooper; Stephen H Gillespie; Timothy D McHugh
Journal:  J Infect Dis       Date:  2012-03-22       Impact factor: 5.226

8.  Probing hot spots at protein-ligand binding sites: a fragment-based approach using biophysical methods.

Authors:  Alessio Ciulli; Glyn Williams; Alison G Smith; Tom L Blundell; Chris Abell
Journal:  J Med Chem       Date:  2006-08-10       Impact factor: 7.446

9.  Quantifying biogenic bias in screening libraries.

Authors:  Jérôme Hert; John J Irwin; Christian Laggner; Michael J Keiser; Brian K Shoichet
Journal:  Nat Chem Biol       Date:  2009-05-31       Impact factor: 15.040

10.  Chemical substructures that enrich for biological activity.

Authors:  Justin Klekota; Frederick P Roth
Journal:  Bioinformatics       Date:  2008-09-10       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.